279 related articles for article (PubMed ID: 37170653)
1. The evolving landscape of immunotherapy for the treatment of allergic conditions.
Pandya A; Adah E; Jones B; Chevalier R
Clin Transl Sci; 2023 Aug; 16(8):1294-1308. PubMed ID: 37170653
[TBL] [Abstract][Full Text] [Related]
2. Immunobiologic treatments for severe asthma, atopic dermatitis, and chronic urticaria.
Chiarella SE
Allergy Asthma Proc; 2019 Nov; 40(6):485-489. PubMed ID: 31690400
[TBL] [Abstract][Full Text] [Related]
3. Strategies for choosing a biologic for your patient with allergy or asthma.
Saco T; Ugalde IC; Cardet JC; Casale TB
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):627-637. PubMed ID: 34642091
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I; Beltran J; Akdis C; Akdis M; Canelo-Aybar C; Canonica GW; Casale T; Chivato T; Corren J; Del Giacco S; Eiwegger T; Firinu D; Gern JE; Hamelmann E; Hanania N; Mäkelä M; Hernández-Martín I; Nair P; O'Mahony L; Papadopoulos NG; Papi A; Park HS; Pérez de Llano L; Posso M; Rocha C; Quirce S; Sastre J; Shamji M; Song Y; Steiner C; Schwarze J; Alonso-Coello P; Palomares O; Jutel M
Allergy; 2020 May; 75(5):1023-1042. PubMed ID: 32034960
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation.
L Ramos C; Namazy J
Immunol Allergy Clin North Am; 2023 Feb; 43(1):187-197. PubMed ID: 36411004
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity and adverse reactions to biologics for asthma and allergic diseases.
Jackson K; Bahna SL
Expert Rev Clin Immunol; 2020 Mar; 16(3):311-319. PubMed ID: 31994421
[No Abstract] [Full Text] [Related]
7. Targeted Molecular Therapies in Allergy and Rhinology.
Damask CC; Ryan MW; Casale TB; Castro M; Franzese CB; Lee SE; Levy JM; Lin SY; Lio PA; Peters AT; Platt MP; White AA
Otolaryngol Head Neck Surg; 2021 Jan; 164(1_suppl):S1-S21. PubMed ID: 33138725
[TBL] [Abstract][Full Text] [Related]
8. Safety of Biologics for Atopic Diseases During Pregnancy.
Shakuntulla F; Chiarella SE
J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3149-3155. PubMed ID: 35987486
[TBL] [Abstract][Full Text] [Related]
9. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis.
Arasi S; Costa S; Magazzù G; Ieni A; Crisafulli G; Caminiti L; Chiera F; Vaccaro M; Del Giudice MM; Pajno GB
Ital J Pediatr; 2016 Mar; 42():32. PubMed ID: 27000314
[TBL] [Abstract][Full Text] [Related]
11. Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis.
Holm JG; Sørensen JA; Thomsen SF
Int J Dermatol; 2022 May; 61(5):e173-e174. PubMed ID: 34813086
[No Abstract] [Full Text] [Related]
12. Biologics for Asthma and Allergic Skin Diseases in Children.
De Keyser HH; Chipps B; Dinakar C;
Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34663682
[TBL] [Abstract][Full Text] [Related]
13. Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps.
Mandl HK; Miller JE; Beswick DM
Otolaryngol Clin North Am; 2024 Apr; 57(2):225-242. PubMed ID: 37684154
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis - A Real-life Experience.
Abuzakouk M; Ghorab OKHA; Wahla AS; Zoumot Z; Nasir M; Grandon D; Uzbeck MH; Salvo F; Shafiq I
Open Respir Med J; 2020; 14():99-106. PubMed ID: 33717370
[TBL] [Abstract][Full Text] [Related]
15. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
[TBL] [Abstract][Full Text] [Related]
16. IgE and eosinophils as therapeutic targets in asthma.
Patel TR; Sur S
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):42-49. PubMed ID: 27906698
[TBL] [Abstract][Full Text] [Related]
17. An update on biological therapies for pediatric allergic diseases.
Castagnoli R; De Filippo M; Votto M; Marseglia A; Montagna L; Marseglia GL; Licari A
Minerva Pediatr; 2020 Oct; 72(5):364-371. PubMed ID: 32686927
[TBL] [Abstract][Full Text] [Related]
18. A pragmatic guide to choosing biologic therapies in severe asthma.
Kavanagh JE; Hearn AP; Jackson DJ
Breathe (Sheff); 2021 Dec; 17(4):210144. PubMed ID: 35296105
[TBL] [Abstract][Full Text] [Related]
19. Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future.
Ramírez-Jiménez F; Pavón-Romero GF; Velásquez-Rodríguez JM; López-Garza MI; Lazarini-Ruiz JF; Gutiérrez-Quiroz KV; Teran LM
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259416
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab for treatment of refractory severe atopic dermatitis. A pediatric perspective.
Iannelli M; Caminiti L; Vaccaro M; Marafioti I; Spinuzza A; Panasiti I; Barbalace A; Crisafulli G; Pajno GB
Dermatol Ther; 2020 Jul; 33(4):e13519. PubMed ID: 32378300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]